Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 9,720.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,720.36% |
Triumph (TGI) | 1,447.6% |
Abivax SA American Depositary Shares (ABVX) | 872.93% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 867.87% |
TMC the metals (TMC) | 331.58% |
Celcuity LLC (CELC) | 291.75% |
Pagaya Technologies (PGY) | 250.16% |
ViaSat (VSAT) | 207.95% |
CommScope (COMM) | 194.68% |
Centrus Energy (LEU) | 171.64% |
Ascentage Pharma Group International (AAPG) | 160.84% |
Sharplink Gaming (SBET) | 158.46% |
IHS (IHS) | 141.1% |
SSR Mining (SSRM) | 138.35% |
Sibanye Gold Ltd ADR (SBSW) | 137.54% |
Tutor Perini (TPC) | 131.82% |
Dave (DAVE) | 128.23% |
Verona Pharma PLC ADR (VRNA) | 125.32% |
Liquidia Technologies (LQDA) | 119.73% |
Sezzle Inc Common Stock (SEZL) | 111.59% |
American Superconductor (AMSC) | 110.14% |
New Gold (NGD) | 107.57% |
Life360, Inc Common Stock (LIF) | 104.28% |
D-Wave Quantum (QBTS) | 100.12% |
Coeur Mining (CDE) | 99.49% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
